Pricing Log in Create free account
Saturday 17 October 2026 Export DXCM’s income statement to Excel — free account

DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue grew 13.1%, EPS grew 41.3%, free cash flow fell 11.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

86.06 1.65 −1.88%
Market cap
$33.1B
P/E
33.2×
Fwd P/E
29.8×
Dividend yield
—
F-score
8/9
Altman Z
6.43
Beneish M
−2.70
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

DexCom, Inc. (DXCM) Gross margin

Alert me on Gross margin

DexCom, Inc.'s gross margin over the twelve months to 30 June 2026 was 62.5%, up 2.4 percentage points from fiscal 2025 (60.1%). Over the past ten years it has ranged from 60.1% (fiscal 2025) to 69.3% (fiscal 2015) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 56.0% and above the Healthcare sector median of 53.5%.

Gross margin, annual

Embed this chart

Annual newest first

Period Gross margin Change (points)
FY2025 60.1% (0.36)
FY2024 60.5% (2.73)
FY2023 63.2% (1.53)
FY2022 64.7% (3.91)
FY2021 68.6% 2.19
FY2020 66.4% 3.33
FY2019 63.1% (1.25)
FY2018 64.4% (4.13)
FY2017 68.5% 2.49
FY2016 66.0% (3.25)

Quarterly newest first

Period Gross margin Change (points)
Jun 2026 63.4% 0.49
Mar 2026 63.0% 0.02
Dec 2025 62.9% 2.45
Sep 2025 60.5% 0.95
42 more quarters

Against its own ten years

Low 60.1% High 69.3%
Ten-year median 64.7%
Current reading's percentile 19

Gross margin against peers

Company Gross margin
EW Edwards Lifesciences Corporation compare 77.8%
SNN Smith & Nephew SNATS, Inc. compare 70.5%
BSX Boston Scientific Corporation compare 69.9%
ZBH Zimmer Biomet Holdings, Inc. compare 69.9%
PEN Penumbra, Inc. compare 67.8%
DXCM DexCom, Inc. 62.5%
PHG Koninklijke Philips N.V. compare 45.9%
STE STERIS plc compare 44.4%
GEHC GE HealthCare Technologies Inc. compare 39.5%
Medical Devices industry median 56.0%
Healthcare sector median 53.5%
Market median 46.2%

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on DXCM